Showing 1481-1490 of 1746 results for "".
- American Academy of Optometry Foundation Announces the 2019 Beta Sigma Kappa (BSK) Research Fellowship Recipienthttps://modernod.com/news/american-academy-of-optometry-foundation-announces-the-2019-beta-sigma-kappa-bsk-research-fellowship-recipient/2476908/The American Academy of Optometry Foundation (AAOF) in collaboration with the Beta Sigma Kappa International Optometric Honor Society, has announced Sima T. Mozdbar, OD, as the 2019 recipient of the Beta Sigma Kappa (BSK) Research Fellowship. Dr. Mozdbar is an Adjunct Clinical Professor at the Un
- American Academy of Optometry Foundation Announces 2019 Fredric Rosemore Low Vision Educational Grant Recipienthttps://modernod.com/news/american-academy-of-optometry-foundation-announces-2019-fredric-rosemore-low-vision-educational-grant-recipient/2476860/The American Academy of Optometry Foundation (AAOF), in collaboration with the Fredric and Marion Rosemore Family Foundation, has announced that So-Yeon Sharon Lee, OD, FAAO, Dipl-ABO, was named the 2019 recipient of the Fredric Rosemore Low Vision Educational Grant. Dr. Lee is an Assistan
- The American Academy of Optometry Foundation Selects the 2019 Bert C. and Lydia M. Corwin Contact Lens Residency Award Recipienthttps://modernod.com/news/the-american-academy-of-optometry-foundation-selects-the-2019-bert-c-and-lydia-m-corwin-contact-lens-residency-award-recipient/2476831/The American Academy of Optometry has named Jocelyn Ou, OD, this year’s recipient of the Bert C. and Lydia M. Corwin Contact Lens Residency award. Dr. Ou is a cornea and contact lens resident at the Ketchum Health University Eye Center in Anaheim, California, and was ch
- The Number of Optometric Practices Offering neurolens Contoured Prism Lenses More Than Quadrupled in 2018https://modernod.com/news/the-number-of-optometric-practices-offering-neurolens-contoured-prism-lenses-more-than-quadrupled-in-2018/2479617/Costa Mesa, California-based neurolens announced that adoption of their prescription lenses has grown among US optometric (OD) practices and by year end, 31 states will carry the company’s neurolenses and the neurolens measurement device. neurolenses are the first and only prescripti
- Prospective Study for NaturalVue Multifocal Demonstrates Decreased Refractive Error Change in Fast-Progressing Myopic Childrenhttps://modernod.com/news/prospective-study-for-naturalvue-multifocal-demonstrates-decreased-refractive-error-change-in-fast-progressing-myopic-children/2479681/Thomas Aller, OD, presented updated findings from a prospective clinical trial of NaturalVue (etafilcon A) 1 Day Multifocal Contact Lenses at a briefing for media and industry leaders at the American Academy of Optometry (AAO) Conference in San Antonio on November 9. The NaturalVue portfolio of p
- Non-Contact Panretinal Photocoagulation for Navilas 577s Introduced at AAO 2018https://modernod.com/news/non-contact-panretinal-photocoagulation-for-navilas-577s-introduced-at-aao-2018/2479753/At the AAO 2018 meeting in Chicago, OD-OS is launching a new widefield objective which brings non-contact panretinal photocoagulation with access to the far periphery (ora serrata) to the Navilas 577s Laser System. The new option for peripheral treatments can further enhance compliance of sensiti
- Silicon Valley Eye Doctor Named Optometrist of the Year By American Optometric Associationhttps://modernod.com/news/silicon-valley-eye-doctor-named-optometrist-of-the-year-by-american-optometric-association/2480071/The California Optometric Association (COA) announced that David M. Redman, OD, has been named the “Optometrist of the Year” for 2017 by the American Optometric Association (AOA). Dr. Redman is a practicing optometrist and partner in Precision Eyecare Centers in San Jose and Mountain View. Dr. Re
- Visus Therapeutics Announces Positive Topline Clinical Data from Phase 3 Trial of Brimochol PF for the Treatment of Presbyopiahttps://modernod.com/news/visus-therapeutics-announces-positive-topline-clinical-data-from-phase-3-trial-of-brimochol-pf-for-the-treatment-of-presbyopia/2481543/Visus Therapeutics reported positive topline results from its phase 3 pivotal BRIO-I trial. BRIO-I met the prespecified primary study endpoints agreed upon with the FDA and EMA/MHRA, demonstrating contribution of elements for the once-daily, fixed-dose combination, Brimochol PF, over both ac
- jCyte Promotes Dr. Shannon Blalock to Chief Executive Officerhttps://modernod.com/news/jcyte-promotes-dr-shannon-blalock-to-chief-executive-officer/2478840/jCyte announced the Board of Directors has promoted Shannon Blalock, PharmD, to Chief Executive Officer, and an elected member of the Board. Dr. Blalock joined jCyte last year as its Chief Operating Officer. “I am thrilled to announce the appointment of Shannon as jCyte’s new CEO at this i
- NORA Issues Response to Medical Groups' Joint Guidance of Vision Disorders Following a Concussionhttps://modernod.com/news/nora-response-to-medical-groups-joint-guidance-of-vision-disorders-following-a-concussion/2480978/Below is the response from the Neuro Optometric Rehabilitation Association (NORA) regarding the recent statement from various ophthalmic organizations i